Ocular Therapeutix Inc (OCUL NASDAQ) stock market data APIs
$6.9383
0.41(5.9%)
as of October 2, 2026
Try our APIs with
free plan!
Ocular Therapeutix Inc Financial Data Overview
Price chart is built with
Anychart
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and non-proliferative diabetic retinopathy; OTX-TIC, a travoprost intracameral hydrogel, which has completed phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
Prev. Close
6.9383
Open
7.3531
High
7.3736
Low
6.8921
52 wk Range
6.23-16.44
Market Cap
1 529 M
Shares Outstanding
220 M
Revenue
52 055 K
EPS
-0.35
Beta
0.968
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Ocular Therapeutix Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Ocular Therapeutix Inc data using free add-ons & libraries
Get Ocular Therapeutix Inc Fundamental Data
Ocular Therapeutix Inc Fundamental data includes:
- Net Revenue: 52 055 K
- EBITDA: -308 457 984
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-03
- EPS/Forecast: -0.4
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ocular Therapeutix Inc News
New
3 of Wall Street’s Favorite Stocks That Fall Short
3 of Wall Street's Favorite Stocks That Fall Short Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it's important to remai...
Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know
Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened,...
Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst?
In the high-stakes realm of clinical-stage biotechnology, long-term shareholder value is fundamentally forged by pipeline assets that solve deep-seated clinical bottlenecks while offering significant ...
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix, Inc. BEDFORD, Mass., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular" or the "Company"), an integrated biopharmaceutical company committed to re...
Get Ocular Therapeutix Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.